Director: Alessandro Mattina

The Diabetes Unit is responsible for the diagnosis and treatment of patients with diabetes mellitus, either on the organ transplant list or post-transplant, for the evaluation of indications for pancreas or pancreatic islet transplantation, or in follow-up at ISMETT for highly specialized therapies.

The Unit employs the most advanced pharmacological treatments and manages the technological tools necessary for a personalized approach to the patient, offering all therapeutic strategies up to isolated pancreas transplantation or combined with kidney transplantation. Patients eligible for a pancreas transplant undergo a multidisciplinary medical and surgical evaluation, are supported throughout the therapeutic process before surgery, and are followed for post-transplant follow-up.

Special emphasis is placed on a multidisciplinary approach to patient management, which involves, among others, the Hepatology Unit, the Dietetics Service, and the Clinical Psychology Service. Patients at high cardiovascular risk or with heart failure are co-managed with the Cardiology Unit.

The Unit is engaged in clinical research activities on diabetes and metabolism, developing experimental protocols and promoting and participating in multicenter projects. It also benefits from the expertise of Prof. Camillo Ricordi, Chairman of the ISMETT Board of Directors and Emeritus Director of the Diabetes Research Institute at the University of Miami, one of the world’s leading centers in diabetes research and pancreatic islet transplantation.